ArrayExpress Uploader0mouse0jak1i0jak1i0jak1i6jak1i6jak1i6jak1i12jak1i12jak1i12jak1i24jak1i24jak1i0jak3i0jak3i0jak3i6jak3i6jak3i6jak3i12jak3i12jak3i12jak3i24jak3i24jak3i0PBS0PBS0PBS6PBS6PBS6PBS12PBS12PBS12PBS7222arrayexpress_sid6Our goal was to identify gene expression patterns that correlated with treatment of established autoimmune alopecia in C3H/HeJ mice...E-GEOD-45514/profile/8773/arrayexpressuploader231alopeciapointskinDec.12, 2014FalseE-GEOD-45514_A-AFFY-45treatment-of-established-mouse-aa-with-topical-jakTreatment of established mouse AA with topical JAK inhibitorsNov.12, 2014Our goal was to identify gene expression patterns that correlated with treatment of established autoimmune alopecia in C3H/HeJ mice following alopecic graft transplantation skin from 3 mice were taken at 6, 12 and, in some cases, 24 weeks of topical drug administration following grafting; mice were treated with ruxolitinib (jak1i), tofacitinib (jak3i), or control pbs 3 biological replicates were taken at each time point for each treatment modalityhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-45514http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-45514/samples/